SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Maya who wrote (2696)12/7/1997 11:13:00 PM
From: ted birnbaum  Read Replies (1) | Respond to of 78594
 
LUKN - as a value play it has merit and I think it has made its bottom
at 2 and bounced off.

Trailing PE : 17
Forward PE : 4
Book Value : 2.81
Case Per SH : .04
Price to sales: 1.07
Rated with 2 strong buys.

Low Float 1m shares, and thinly traded Avg Vol ~20k per day



To: Maya who wrote (2696)12/8/1997 12:24:00 AM
From: Paul Senior  Read Replies (1) | Respond to of 78594
 
Maya: interesting way you have of valuing companies. Technology dollars invested (spent) become an asset. Somebody else - one of those medical technology letter writers or portfolio managers I think - does it based on technology spending over 5 years. Well why not? Those companies don't have any sales or earnings mostly. Now the added twist is that you value the people and the board at 50c per share. I like that. Looks like 180 people per Yahoo report. Let's see. With 5 top American CEO's on the board, how can I apportion the 50c per share? How about 2c for all the people and 48c for all the CEO's and the others on the board? No that can't be right. I want it allocated so that the more people they hire the more the 50c grows. No, it's probably better if I do it for a stock I own like APM. I'll just calculate all the money they put into R&D and add it back to book value. Surely too, I could add a few c per share for all the people they've got on their board too. I like it -g-.